According to analyze published in PLoS Genetics.

Presently, there are fewer treatment plans for women with hormone independent breasts cancer following surgery. Cancer Study UK’s Dr Paul Pharoah, lead author based at the University of Cambridge, said: ‘We looked at five genetic variants connected with breast tumor to see if indeed they were more most likely found in hormone dependent or independent breasts cancers. Related StoriesStudy shows rare HER2 missense mutations usually do not spread breast cancer on their ownOvarian cancer patients with a history of oral contraceptive use have better outcomesScientists discover little molecule that can block growth of BRCA-deficient tumor cells’One common genetic variant, FGFR2, was strongly connected with hormone dependent breasts cancer, but weakly connected with hormone independent cancer.Related StoriesExpanded use for IntelliCap with additional CE Tag for aspiration of fluidsStudy links antibiotic use during childhood to fat gainArtemisinin and the fight against malaria: an interview with Dr. Robert Sebbag, Sanofi The Fast Track program of the FDA is designed to facilitate the advancement and expedite the overview of new medicines that are intended to treat serious or life-threatening conditions and that demonstrate the potential to handle unmet medical requirements.